{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:26:05Z","timestamp":1778653565464,"version":"3.51.4"},"reference-count":8,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Centers of Excellence for Influenza Research and Response (CEIRR)","award":["75N93021C00016"],"award-info":[{"award-number":["75N93021C00016"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Centers of Excellence for Influenza Research and Response (CEIRR)","award":["75N93019C00052"],"award-info":[{"award-number":["75N93019C00052"]}]},{"name":"Collaborative Influenza Vaccine Innovation Centers (CIVICs)","award":["75N93021C00016"],"award-info":[{"award-number":["75N93021C00016"]}]},{"name":"Collaborative Influenza Vaccine Innovation Centers (CIVICs)","award":["75N93019C00052"],"award-info":[{"award-number":["75N93019C00052"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>\u00a0Newly emerging and seasonal respiratory viruses have a great impact on public health[...]<\/jats:p>","DOI":"10.3390\/v14061160","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T05:25:42Z","timestamp":1653974742000},"page":"1160","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel Vaccines and Drugs That Target the Surface Glycoproteins of Influenza Viruses, RSV, Parainfluenza Viruses, and SARS-CoV-2"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-3990","authenticated-orcid":false,"given":"Charles J.","family":"Russell","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children\u2019s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena A.","family":"Govorkova","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children\u2019s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Narkhede, Y.B., Gonzalez, K.J., and Strauch, E.M. (2021). Targeting Viral Surface Proteins through Structure-Based Design. Viruses, 13.","DOI":"10.3390\/v13071320"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tripp, R.A., and Stambas, J. (2021). Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins. Viruses, 13.","DOI":"10.3390\/v13040625"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Nagashima, K.A., and Mousa, J.J. (2021). Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine. Viruses, 13.","DOI":"10.3390\/v13040546"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wiggins, K.B., Smith, M.A., and Schultz-Cherry, S. (2021). The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations. Viruses, 13.","DOI":"10.3390\/v13061109"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Vajo, Z., Balaton, G., Vajo, P., and Torzsa, P. (2021). A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients. Viruses, 13.","DOI":"10.3390\/v13030500"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bai, Y., Jones, J.C., Wong, S.S., and Zanin, M. (2021). Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance. Viruses, 13.","DOI":"10.3390\/v13040624"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Russell, C.J., and Hurwitz, J.L. (2021). Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses. Viruses, 13.","DOI":"10.3390\/v13061023"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hurt, A.C., and Wheatley, A.K. (2021). Neutralizing Antibody Therapeutics for COVID-19. Viruses, 13.","DOI":"10.3390\/v13040628"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1160\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:19:37Z","timestamp":1760138377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":8,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["v14061160"],"URL":"https:\/\/doi.org\/10.3390\/v14061160","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]}}}